• Nicotine’s Role in Chronic Kidney Disease Progression: Mecha

  2026-05-09

  This review elucidates the mechanistic links between nicotine exposure and the progression of chronic kidney disease (CKD), highlighting the role of non-neuronal nicotinic acetylcholine receptors, oxidative stress, and pro-fibrotic signaling. The findings underscore nicotine’s direct impact on renal pathology and outline emerging experimental approaches for translational kidney research.

• Belinostat (PXD101): Potent HDAC Inhibition for Cancer Resea

  2026-05-08

  Belinostat (PXD101) is a hydroxamate-type pan-HDAC inhibitor with nanomolar potency, widely used in epigenetic cancer research. It demonstrates robust cell cycle arrest and tumor growth inhibition across multiple carcinoma models, establishing itself as a benchmark compound for mechanistic and translational studies.

• Triamcinolone: Protocols and Guidance for Glucocorticoid Res

  2026-05-07

  Triamcinolone is a synthetic glucocorticoid agonist designed for controlled studies of glucocorticoid receptor signaling, inflammatory processes, and immunosuppression in cellular models. It is not suitable for diagnostic or clinical use, and specialized handling is required due to its solubility and storage characteristics.

• Morning Endurance Training Yields Superior Muscle Adaptation

  2026-05-07

  Hesketh et al. (2026) demonstrate that morning (early active phase) endurance training in mice produces more pronounced improvements in endurance performance and skeletal muscle adaptation versus afternoon training, despite lower training volumes. These findings highlight exercise timing as a crucial experimental variable for studies of metabolic adaptation and circadian biology.

• Ceftolozane/Tazobactam: Innovations for Resistant Gram-Negat

  2026-05-06

  The reference review details the unique pharmacological properties of ceftolozane/tazobactam, a novel cephalosporin/beta-lactamase inhibitor combination with enhanced efficacy against multidrug-resistant gram-negative pathogens. Its clinical relevance lies in treating complicated intraabdominal and urinary tract infections, particularly where existing antibiotics are failing.

• Lysosomal β-Galactosidase Staining Kit: Redefining Senescenc

  2026-05-06

  Explore the Lysosomal β-Galactosidase Staining Kit as a foundation for rigorous, artifact-free validation of senescence biomarkers. Discover advanced assay rationale, protocol insights, and translational guidance integrating recent mechanistic oncology breakthroughs.

• Hypoxia, Choroid Plexus Barrier Disruption, and Cognitive Im

  2026-05-05

  This study uncovers how simulated high-altitude hypoxia impairs cognition in mice by disrupting the choroid plexus barrier and inducing M1 macrophage polarization through aberrant AMPK signaling and oxidative stress. These mechanistic insights reveal new therapeutic targets for mitigating hypoxia-induced central nervous system dysfunction.

• PEDV Hijacks IMPDH-Dependent Nucleotide Metabolism for Repli

  2026-05-05

  This study demonstrates that porcine epidemic diarrhea virus (PEDV) reprograms host nucleotide metabolism, specifically targeting IMPDH-dependent guanine biosynthesis, to facilitate its replication. Both genetic and pharmacological inhibition of IMPDH—including with Merimepodib (VX-497)—significantly impairs PEDV replication, establishing IMPDH as a promising host-directed antiviral target.

• Neuroinflammation and Piezo2 in Trigeminal Neuralgia Allodyn

  2026-05-04

  Liao et al. identify a neuroinflammatory mechanism in trigeminal neuralgia (TN), linking ATP-driven signaling and mechanosensitive Piezo2 channels to pain hypersensitivity. This work advances our understanding of TN pathogenesis and highlights new molecular targets for sensory pain modulation.

• Sulfo-Cy3 NHS Ester: Next-Gen Fluorescent Labeling for Prote

  2026-05-04

  Explore how Sulfo-Cy3 NHS Ester, a hydrophilic fluorescent dye, redefines quantitative analysis of protein–cell interactions. This article uniquely connects advanced conjugation chemistry with decisive vascular biology insights for transformative research applications.

• Evaluating Drug Responses in Cancer: In Vitro Method Advance

  2026-05-03

  Schwartz's dissertation introduces a nuanced approach to in vitro anti-cancer drug evaluation by differentiating between proliferative arrest and cell death. This distinction provides researchers with a more granular understanding of drug actions, enabling improved experimental design and interpretation in cancer research.

• Oleanolic Acid in Precision Encapsulation: Innovations & Imm

  2026-05-02

  Explore how Oleanolic acid advances encapsulation efficiency and immune pathway research. This article uniquely integrates assay innovation with mechanistic insight for inflammation and antiviral studies.

• Chlorambucil (SKU B3716): Data-Driven Solutions for In Vitro

  2026-05-02

  This article provides advanced, scenario-driven guidance for biomedical researchers and technicians using Chlorambucil (SKU B3716) in cell viability, proliferation, and cytotoxicity assays. Drawing on validated literature and product dossier data, it addresses real laboratory challenges—ranging from solubility optimization to vendor reliability—while illustrating best practices for reproducible and interpretable results.

• SGI-1027: DNA Methyltransferase Inhibitor for Cancer Epigene

  2026-05-01

  SGI-1027 stands out as a DNA methyltransferase inhibitor enabling robust, selective DNA methylation inhibition and reactivation of silenced tumor suppressor genes in cancer models. This guide delivers practical workflow enhancements, troubleshooting insights, and evidence-based protocol recommendations to maximize experimental success in epigenetic cancer research.

• Lopinavir (ABT-378): Precision HIV Protease Inhibition and T

  2026-04-30

  Discover how Lopinavir (ABT-378) advances HIV protease inhibition with unmatched selectivity and serum stability. This article explores new evidence for its application in resistance and cross-viral research, offering a deeper, protocol-driven perspective.

453 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page